Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Solutions for the temperature-induced challenges for Integrated Circuits

Author: Mansour KhatibAn Electro-Thermal aware design environment system is the best solution for detecting thermal flaws and weaknesses to ensure reliable, high-performance integrated circuits....
Research | September 29, 2022 |

An untapped value play in chrome and PGM

As commodity prices continue to soar due to COVID-induced supply shortages, the Russia-Ukraine war and record inflation, metals producers are occupying an enviable position in the global investmen...
Trevor Abes | June 9, 2022 |

Three business reasons companies need to recycle e-waste

Author: Lane Simond . The most common narrative about recycling electronics is that it is better for the environment, but business owners have even more reasons to make sure their outdated technology gets into the hands of a reputable recycler. Three reasons to...
Research | December 18, 2024 |

The Fed Induced Twilight-Zone

The past three weeks have been filled with intense drama, incredible highs and lows, political battles that continue to this day, and millions of questions from people throughout the world. Throughout this COVID-19 virus event and the collapse of the US and global markets, o...
Chris Vermeulen | April 20, 2020 |

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. Clinical-stage biopharmaceutical company Fate Thera...
Streetwise Reports | April 7, 2020 |

A psychedelic renaissance

Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...
Richard (Rick) Mills | December 3, 2019 |

Will Stocks Keep Cutting Through Supports Like a Hot Knife Through Butter?

During the first half of yesterday’s session, the bulls were in the driving seat after repelling sellers at the open. Yet again, their gains have evaporated, and stocks not only broke to new lows, but also closed there. Will today’s session be a...
Monica Kingsley | March 2, 2020 |

Positive Cash Flow Extractor Manufacturer Turns its Mind to Psychedelics

“It’s all about visibility.” That’s how Calgary, AB-based MedXtractor Corp. (MXT) ( CSE.MXT , Forum ) is changing both the future of cannabis extraction and the burgeoning mental health science of psychedelics. ...
Dave Jackson | January 15, 2021 |

Where Next After the Daily S&P 500 Consolidation?

With yesterday's hefty gains taken off the table, and a new profitable position that has them secured already, will the S&P 500 let me add to the tally some more still today? Given yesterday's Powell-testimony-induced wild swings and preceding strong retail sales data, it's no...
Monica Kingsley | June 17, 2020 |

Analyst: G1 Minimizes the Carnage of Chemotherapy

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. In a June 26 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on G1 Therapeutics Inc. (GTHX:NASDAQ) with a Buy ...
Streetwise Reports | July 2, 2020 |
1 2 3 4 5 6 7 8